EDWARDS LIFESCIENCES CORP (EW) Forecast, Price Target & Analyst Ratings
NYSE:EW • US28176E1082
83 USD
-0.89 (-1.06%)
Last: Mar 6, 2026, 02:22 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EDWARDS LIFESCIENCES CORP (EW).
Forecast Snapshot
Consensus Price Target
$97.45
+ 17.41% Upside
Next Earnings Forecast
Release DateApr 21, 2026
PeriodQ1 / 2026
EPS Estimate$0.75
Revenue Estimate1.645B
ChartMill Buy Consensus
79.53%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$97.45
Upside
+ 17.41%
From current price of $83.00 to mean target of $97.45, Based on 43 analyst forecasts
Low
$72.72
Median
$100.98
High
$115.50
Price Target Revisions
1 Month
-0.55%
3 Months
2.64%
Price Target Summary
43 analysts have analysed EW and the average price target is 97.45 USD. This implies a price increase of 17.41% is expected in the next year compared to the current price of 83.
The average price target has been revised upward by 2.64% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
79.53%
EW was analyzed by 43 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about EW.
In the previous month the buy percentage consensus was at a similar level.
EW was analyzed by 43 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-11 | BTIG | Reiterate | Buy -> Buy |
| 2026-02-11 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-11 | Truist Securities | Maintains | Hold -> Hold |
| 2026-02-11 | Goldman Sachs | Maintains | Buy -> Buy |
| 2026-02-11 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2026-01-20 | Stifel | Maintains | Buy -> Buy |
| 2026-01-20 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-12 | UBS | Maintains | Neutral -> Neutral |
| 2026-01-12 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-09 | TD Cowen | Upgrade | Hold -> Buy |
| 2026-01-07 | Stifel | Maintains | Buy -> Buy |
| 2025-12-18 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-12-17 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-12-16 | Baird | Maintains | Neutral -> Neutral |
| 2025-12-11 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-05 | BTIG | Maintains | Buy -> Buy |
| 2025-12-05 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-05 | Stifel | Maintains | Buy -> Buy |
| 2025-12-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-05 | Truist Securities | Maintains | Hold -> Hold |
| 2025-12-05 | Baird | Maintains | Neutral -> Neutral |
| 2025-12-05 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-11-25 | BTIG | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 21, 2026
PeriodQ1 / 2026
EPS Estimate$0.75
Revenue Estimate1.645B
Revenue Q2Q16.44%
EPS Q2Q16.74%
Number of Analysts30
Next Earnings Revisions
Revenue (1 Month)
1.79%
Revenue (3 Months)
1.61%
EPS (1 Month)
5.73%
EPS (3 Months)
6.29%
Next Earnings Summary
EW is expected to report earnings on 4/21/2026. The consensus EPS estimate for the next earnings is 0.75 USD and the consensus revenue estimate is 1.65B USD.
The next earnings revenue estimate has been revised upward by 1.61% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.01B 12.23% | 5.44B 8.57% | 6.068B 11.55% | 6.868B 13.19% | 7.542B 9.81% | 8.301B 10.06% | 8.926B 7.53% | 9.884B 10.73% | |
| EBITDA YoY % growth | 1.657B -3.34% | 1.635B -1.33% | 1.805B 10.40% | 2.15B 19.09% | 2.405B 11.86% | 2.673B 11.14% | 3.06B 14.48% | 3.394B 10.92% | |
| EBIT YoY % growth | 1.512B -3.97% | 1.48B -2.14% | 1.649B 11.39% | 1.967B 19.31% | 2.206B 12.15% | 2.496B 13.15% | 2.734B 9.54% | 3.07B 12.29% | |
| Operating Margin | 30.19% | 27.21% | 27.17% | 28.64% | 29.25% | 30.07% | 30.63% | 31.06% | |
| EPS YoY % growth | 2.51 1.21% | 2.62 4.38% | 2.56 -2.29% | 2.97 16.14% | 3.29 10.60% | 3.70 12.37% | 4.16 12.57% | 4.67 12.34% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.75 16.74% | 0.77 15.15% | 0.75 12.67% | 0.75 28.85% | 0.76 2.36% | 0.83 7.14% | 0.83 10.52% | 0.87 16.46% |
| Revenue Q2Q % growth | 1.645B 16.44% | 1.734B 13.17% | 1.737B 11.84% | 1.745B 11.17% | 1.747B 6.20% | 1.88B 8.42% | 1.875B 7.94% | 1.937B 11.00% |
| EBITDA Q2Q % growth | 529.52M 18.59% | 547.36M 8.26% | 537.71M -2.50% | 532.86M 1.13% | 561.05M 5.95% | 600.97M 9.79% | 607.22M 12.93% | 625.27M 17.34% |
| EBIT Q2Q % growth | 486.72M 18.74% | 503.84M 16.93% | 495.88M 13.32% | 490.25M 32.39% | 504.63M 3.68% | 544.99M 8.17% | 549.32M 10.78% | 584.45M 19.21% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
13.01%
EPS Next 5 Year
12.79%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
10.12%
Revenue Next 5 Year
9.72%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
16.10%
EBIT Next 5 Year
14.72%
EDWARDS LIFESCIENCES CORP / EW Forecast FAQ
Can you provide the average price target for EDWARDS LIFESCIENCES CORP stock?
43 analysts have analysed EW and the average price target is 97.45 USD. This implies a price increase of 17.41% is expected in the next year compared to the current price of 83.
What is the next earnings date for EW stock?
EDWARDS LIFESCIENCES CORP (EW) will report earnings on 2026-04-21, after the market close.
What are the consensus estimates for EDWARDS LIFESCIENCES CORP (EW) next earnings?
The consensus EPS estimate for the next earnings of EDWARDS LIFESCIENCES CORP (EW) is 0.75 USD and the consensus revenue estimate is 1.65B USD.
How do analysts rate EDWARDS LIFESCIENCES CORP (EW)?
The consensus rating for EDWARDS LIFESCIENCES CORP (EW) is 79.5349 / 100 . This indicates that analysts generally have a positive outlook on the stock.